Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marja-Riitta Taskinen

Showing results (191-200 of 230) with videos related to

Pageof 23
Sort By:
Circulation. Genomic and Precision Medicine|March 11, 2020
Polygenic Hyperlipidemias and Coronary Artery Disease RiskPietari Ripatti, Joel T Rämö, Nina J Mars, et al.
Clinical Chemistry|June 14, 2017
Baseline Circulating FGF21 Concentrations and Increase after Fenofibrate Treatment Predict More Rapid Glycemic Progression in Type 2 Diabetes: Results from the FIELD StudyKwok-Leung Ong, Rachel O'Connell, Andrzej S Januszewski, et al.
Journal of the American Heart Association|July 2, 2019
Coronary Artery Disease Risk and Lipidomic Profiles Are Similar in Hyperlipidemias With Family History and Population-Ascertained HyperlipidemiasJoel T Rämö, Pietari Ripatti, Rubina Tabassum, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 25, 2010
Transcriptional activation of apolipoprotein CIII expression by glucose may contribute to diabetic dyslipidemiaSandrine Caron, An Verrijken, Ilse Mertens, et al.
Revista Espanola De Cardiologia|November 26, 2011
[ESC/EAS Guidelines for the management of dyslipidaemias]Željko Reiner, Alberico L Catapano, Guy De Backer, et al.
Atherosclerosis|August 4, 2017
Family-specific aggregation of lipid GWAS variants confers the susceptibility to familial hypercholesterolemia in a large Austrian familyElina Nikkola, Arthur Ko, Marcus Alvarez, et al.
European Heart Journal|October 23, 2010
Lipoprotein(a) as a cardiovascular risk factor: current statusBørge G Nordestgaard, M John Chapman, Kausik Ray, et al.
European Heart Journal|May 3, 2011
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for managementM John Chapman, Henry N Ginsberg, Pierre Amarenco, et al.
Nutrition & Metabolism|June 25, 2014
Patients with type 1 diabetes show signs of vascular dysfunction in response to multiple high-fat mealsMariann I Lassenius, Ville-Petteri Mäkinen, Christopher L Fogarty, et al.
Molecular Systems Biology|April 28, 2020
The acute effect of metabolic cofactor supplementation: a potential therapeutic strategy against non-alcoholic fatty liver diseaseCheng Zhang, Elias Bjornson, Muhammad Arif, et al.
Pageof 23

Showing results (191-200 of 230) with videos related to

Sort By:
Pageof 23
Circulation. Genomic and Precision Medicine|March 11, 2020
Polygenic Hyperlipidemias and Coronary Artery Disease RiskPietari Ripatti, Joel T Rämö, Nina J Mars, et al.
Clinical Chemistry|June 14, 2017
Baseline Circulating FGF21 Concentrations and Increase after Fenofibrate Treatment Predict More Rapid Glycemic Progression in Type 2 Diabetes: Results from the FIELD StudyKwok-Leung Ong, Rachel O'Connell, Andrzej S Januszewski, et al.
Journal of the American Heart Association|July 2, 2019
Coronary Artery Disease Risk and Lipidomic Profiles Are Similar in Hyperlipidemias With Family History and Population-Ascertained HyperlipidemiasJoel T Rämö, Pietari Ripatti, Rubina Tabassum, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 25, 2010
Transcriptional activation of apolipoprotein CIII expression by glucose may contribute to diabetic dyslipidemiaSandrine Caron, An Verrijken, Ilse Mertens, et al.
Revista Espanola De Cardiologia|November 26, 2011
[ESC/EAS Guidelines for the management of dyslipidaemias]Željko Reiner, Alberico L Catapano, Guy De Backer, et al.
Atherosclerosis|August 4, 2017
Family-specific aggregation of lipid GWAS variants confers the susceptibility to familial hypercholesterolemia in a large Austrian familyElina Nikkola, Arthur Ko, Marcus Alvarez, et al.
European Heart Journal|October 23, 2010
Lipoprotein(a) as a cardiovascular risk factor: current statusBørge G Nordestgaard, M John Chapman, Kausik Ray, et al.
European Heart Journal|May 3, 2011
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for managementM John Chapman, Henry N Ginsberg, Pierre Amarenco, et al.
Nutrition & Metabolism|June 25, 2014
Patients with type 1 diabetes show signs of vascular dysfunction in response to multiple high-fat mealsMariann I Lassenius, Ville-Petteri Mäkinen, Christopher L Fogarty, et al.
Molecular Systems Biology|April 28, 2020
The acute effect of metabolic cofactor supplementation: a potential therapeutic strategy against non-alcoholic fatty liver diseaseCheng Zhang, Elias Bjornson, Muhammad Arif, et al.
Pageof 23